Purchases and Sales Made in Q3 2022 in Imago Bio Sciences, Inc. (IMGO)
This table provides information about the institutional ownership of Imago Bio Sciences, Inc. (IMGO) during Q3 2022. The information is specifically focused on institutions that hold shares of Imago BioSciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-25K- 11.11% |
$354K - $488K
|
200K
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-35.2K- 1.83% |
$498K - $686K
|
1.89M
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-52.3K- 2.08% |
$740K - $1.02M
|
2.46M
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-195K- 88.39% |
$2.76M - $3.8M
|
25.6K
$0
|
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-195K- 88.39% |
$2.76M - $3.8M
|
25.6K
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-215K- 31.98% |
$3.04M - $4.19M
|
457K
$0
|